价格

SEQIRUS PTY LTD

63 Poplar Rd, Parkville, Victoria, 澳大利亚

概览

试验阶段分布

阶段

试验数

占比

不适用

100.0%

试验状态分布

已完成

100.0%

药物批准

按机构分类的批准

TGA

Therapeutic Goods Administration

180

药物批准

CANADA

Health Canada

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

近期批准

SEA SNAKE ANTIVENOM INJECTION

NPRA

2025-11-28

FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe with attached needle (452626)

TGA

2025-07-10

FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free (452625)

TGA

2025-07-10

FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free (452625)

TGA

2025-07-10

FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe with attached needle (452626)

TGA

2025-07-10

AUDENZ Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free (446671)

TGA

2025-06-11

CELLDEMIC Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free (446673)

TGA

2025-06-11

CELLDEMIC Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free (446673)

TGA

2025-06-11

AUDENZ Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free (446671)

TGA

2025-06-11

RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle (473905)

TGA

2025-03-28

资讯

暂无资讯文章

返回机构列表

SEQIRUS PTY LTD

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（1）

A retrospective review of the pre-testing and vaccination using the Q VAX vaccine in Australian meat processor and livestock workers from 2002.

药物批准

按机构分类的批准

近期批准

资讯